Insulet Corporation - Common Stock (NQ:PODD)

205.37 +3.90 (+1.93%)

Streaming Delayed Price Updated: 9:38 AM EDT, Apr 17, 2026 Add to My Watchlist

Price and Volume

Volume	33,098
Open	204.14
Bid (Size)	204.88 (80)
Ask (Size)	205.95 (80)
Prev. Close	201.47
Today's Range	203.98 - 205.95
52wk Range	194.61 - 354.88
Shares Outstanding	68,873,869
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

April 14, 2026

From Pomerantz LLP

Via GlobeNewswire

2 High-Flying Stocks to Own for Decades and 1 We Turn Down

April 09, 2026

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo...

Via StockStory

Performance

YTD	-27.4%	-27.4%
1 Month	-10.9%	-10.9%
3 Month	-28.3%	-28.3%
6 Month	-35.1%	-35.1%
1 Year	-18.1%	-18.1%

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

Insulet (PODD): 3 Reasons We Love This Stock

April 03, 2026

Via StockStory

Insulet Corp (NASDAQ:PODD): A Prime GARP Investment with Strong Growth and Reasonable Valuation ↗

April 02, 2026

Via Chartmill

Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring

April 02, 2026

Via MarketMinute

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

April 01, 2026

From Insulet Corporation

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

March 31, 2026

From Pomerantz LLP

Via GlobeNewswire

What's going on in today's pre-market session: S&P500 movers ↗

March 31, 2026

Via Chartmill

Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring Stocks

March 30, 2026

Via StockStory

Insulet Appoints Mike Panos as Chief Commercial Officer

March 30, 2026

From Insulet Corporation

Via Business Wire

PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm

March 28, 2026

From The Schall Law Firm

Via Business Wire

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

March 27, 2026

Via StockStory

3 S&P 500 Stocks for Long-Term Investors

March 27, 2026

Via StockStory

Stay informed with the top movers within the S&P500 index on Wednesday. ↗

March 25, 2026

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

March 19, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

March 18, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

March 18, 2026

From Law Offices of Howard G. Smith

Via Business Wire

1 Healthcare Stock with Exciting Potential and 2 We Avoid

March 18, 2026

Via StockStory

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

March 17, 2026

From Pomerantz LLP

Via GlobeNewswire

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗

March 15, 2026

Via The Motley Fool

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗

March 15, 2026

Via The Motley Fool

EXCLUSIVE: Just 5 Female CEOs In A 50-Stock ETF — C-Suite Execs Explain The Leadership Gap In Corporate America ↗

March 14, 2026

Via Benzinga

Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

March 13, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Frequently Asked Questions

Is Insulet Corporation - Common Stock publicly traded?

Yes, Insulet Corporation - Common Stock is publicly traded.

What exchange does Insulet Corporation - Common Stock trade on?

Insulet Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Insulet Corporation - Common Stock?

The ticker symbol for Insulet Corporation - Common Stock is PODD on the Nasdaq Stock Market

What is the current price of Insulet Corporation - Common Stock?

The current price of Insulet Corporation - Common Stock is 205.37

When was Insulet Corporation - Common Stock last traded?

The last trade of Insulet Corporation - Common Stock was at 04/17/26 09:38 AM ET

What is the market capitalization of Insulet Corporation - Common Stock?

The market capitalization of Insulet Corporation - Common Stock is 14.14B

How many shares of Insulet Corporation - Common Stock are outstanding?

Insulet Corporation - Common Stock has 14B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.